Antiarrhythmic (Purinergic)
Pregnancy: Use with caution — limited data; used in SVT in pregnancy
Adenosine
Brand names: Adenocor
Adult dose
Dose: 3 mg rapid IV bolus; if no response after 1–2 min: 6 mg; if still no response after 1–2 min: 12 mg
Route: IV rapid bolus into large proximal vein (antecubital or central)
Frequency: Sequential escalating doses
Max: 12 mg per dose
For termination of SVT involving AV node. Must be given as rapid bolus followed by saline flush. Causes transient AV block. Warn patient of chest tightness/flushing. Reduce dose with dipyridamole or cardiac transplant.
Paediatric dose
Dose: 0.1 mg/kg
Route: IV rapid bolus
Frequency: Escalate: 0.1 → 0.2 → 0.3 mg/kg
Max: 12 mg
Concentration: 3 mg/mL mg/ml
Dose 0.1 mg/kg; if no response 0.2 mg/kg; then 0.3 mg/kg. Maximum single dose 12 mg.
Dose adjustments
Renal
No dose adjustment — extremely short half-life (<10 seconds)
Hepatic
No dose adjustment
Paediatric weight-based calculator
Dose 0.1 mg/kg; if no response 0.2 mg/kg; then 0.3 mg/kg. Maximum single dose 12 mg.
Clinical pearls
- Half-life ~10 seconds — must be injected rapidly then flushed immediately
- Always have crash trolley available — transient asystole is expected
- Diagnostic AND therapeutic in SVT — helps distinguish from VT during adenosine administration
- In AF with WPW, adenosine is relatively contraindicated — may precipitate VF via accessory pathway
Contraindications
- Second/third degree AV block (unless paced)
- Sick sinus syndrome (unless paced)
- Asthma/COPD with bronchospasm
- Long QT syndrome
- Atrial flutter/fibrillation with accessory pathway (WPW — may accelerate conduction)
Side effects
- Chest tightness/pain (very common)
- Facial flushing
- Dyspnoea
- Bradycardia/asystole (transient)
- Nausea
- Bronchospasm (in asthmatics — avoid)
Interactions
- Dipyridamole — potentiates effect (reduce adenosine dose to 1 mg, use with extreme caution)
- Theophylline/caffeine — antagonises effect (may need higher doses)
- Carbamazepine — enhanced AV block
Monitoring
- Continuous ECG monitoring during administration
- Blood pressure
- SpO2
- Be ready for defibrillation
Reference: BNFc; BNF; Resuscitation Council UK ACLS Guidelines 2021; ESC SVT Guidelines 2019. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines